Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.

Angenendt L, Bormann E, Pabst C, Alla V, Görlich D, Braun L, Dohlich K, Schwöppe C, Bohlander SK, Arteaga MF, Wethmar K, Hartmann W, Angenendt A, Kessler T, Mesters RM, Stelljes M, Rothenberg-Thurley M, Spiekermann K, Hébert J, Sauvageau G, Valk PJM, Löwenberg B, Serve H, Müller-Tidow C, Lenz G, Wörmann BJ, Sauerland MC, Hiddemann W, Berdel WE, Krug U, Metzeler KH, Mikesch JH, Herold T, Schliemann C.

Leukemia. 2019 Jun 10. doi: 10.1038/s41375-019-0505-x. [Epub ahead of print]

PMID:
31182782
2.

Response assessment in acute myeloid leukemia by flow cytometry supersedes cytomorphology at time of aplasia, amends cases without molecular residual disease marker and serves as an independent prognostic marker at time of aplasia and post-induction.

Köhnke T, Bücklein V, Rechkemmer S, Schneider S, Rothenberg-Thurley M, Metzeler KH, Sauerland MC, Hiddemann W, Spiekermann K, Subklewe M.

Haematologica. 2019 Apr 4. pii: haematol.2018.215236. doi: 10.3324/haematol.2018.215236. [Epub ahead of print]

3.

Reaction time-based Concealed Information Test in eyewitness identification is moderated by picture similarity but not eyewitness cooperation.

Georgiadou K, Chronos A, Verschuere B, Sauerland M.

Psychol Res. 2019 Jan 11. doi: 10.1007/s00426-018-1139-8. [Epub ahead of print]

PMID:
30635707
4.

Showup identification decisions for multiple perpetrator crimes: Testing for sequential dependencies.

Tupper N, Sauerland M, Sauer JD, Broers NJ, Charman SD, Hope L.

PLoS One. 2018 Dec 6;13(12):e0208403. doi: 10.1371/journal.pone.0208403. eCollection 2018.

5.

Developmental trends in lineup performance: Adolescents are more prone to innocent bystander misidentifications than children and adults.

Brackmann N, Sauerland M, Otgaar H.

Mem Cognit. 2019 Apr;47(3):428-440. doi: 10.3758/s13421-018-0877-6.

PMID:
30478519
6.

Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA.

Konstandin NP, Pastore F, Herold T, Dufour A, Rothenberg-Thurley M, Hinrichsen T, Ksienzyk B, Tschuri S, Schneider S, Hoster E, Berdel WE, Woermann BJ, Sauerland MC, Braess J, Bohlander SK, Klein HG, Hiddemann W, Metzeler KH, Spiekermann K.

Blood Adv. 2018 Oct 23;2(20):2724-2731. doi: 10.1182/bloodadvances.2018016840.

7.

Individual differences in eyewitness accuracy across multiple lineups of faces.

Russ AJ, Sauerland M, Lee CE, Bindemann M.

Cogn Res Princ Implic. 2018 Aug 8;3:30. doi: 10.1186/s41235-018-0121-8. eCollection 2018 Dec.

8.

Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia.

Hornung R, Jurinovic V, Batcha AMN, Bamopoulos SA, Rothenberg-Thurley M, Amler S, Sauerland MC, Berdel WE, Wörmann BJ, Bohlander SK, Braess J, Hiddemann W, Lehmann S, Mareschal S, Spiekermann K, Metzeler KH, Herold T, Boulesteix AL.

Sci Rep. 2018 Jul 26;8(1):11293. doi: 10.1038/s41598-018-29593-2.

9.

Warnings to Counter Choice Blindness for Identification Decisions: Warnings Offer an Advantage in Time but Not in Rate of Detection.

Sagana A, Sauerland M, Merckelbach H.

Front Psychol. 2018 Jun 13;9:981. doi: 10.3389/fpsyg.2018.00981. eCollection 2018.

10.

Face value: testing the utility of contextual face cues for face recognition.

Tupper N, Sauer JD, Sauerland M, Fu I, Hope L.

Memory. 2018 Nov;26(10):1436-1449. doi: 10.1080/09658211.2018.1489968. Epub 2018 Jun 22.

PMID:
29932823
11.

Genetics of acute myeloid leukemia in the elderly: mutation spectrum and clinical impact in intensively treated patients aged 75 years or older.

Prassek VV, Rothenberg-Thurley M, Sauerland MC, Herold T, Janke H, Ksienzyk B, Konstandin NP, Goerlich D, Krug U, Faldum A, Berdel WE, Wörmann B, Braess J, Schneider S, Subklewe M, Bohlander SK, Hiddemann W, Spiekermann K, Metzeler KH.

Haematologica. 2018 Nov;103(11):1853-1861. doi: 10.3324/haematol.2018.191536. Epub 2018 Jun 14.

12.

The effects of co-witness discussion on confidence and precision in eyewitness memory reports.

Rechdan J, Hope L, Sauer JD, Sauerland M, Ost J, Merckelbach H.

Memory. 2018 Aug;26(7):904-912. doi: 10.1080/09658211.2018.1448872. Epub 2018 Mar 13.

PMID:
29534645
13.

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Rothenberg-Thurley M, Amler S, Goerlich D, Köhnke T, Konstandin NP, Schneider S, Sauerland MC, Herold T, Hubmann M, Ksienzyk B, Zellmeier E, Bohlander SK, Subklewe M, Faldum A, Hiddemann W, Braess J, Spiekermann K, Metzeler KH.

Leukemia. 2018 Jul;32(7):1598-1608. doi: 10.1038/s41375-018-0034-z. Epub 2018 Feb 23.

14.

Decision time and confidence predict choosers' identification performance in photographic showups.

Sauerland M, Sagana A, Sporer SL, Wixted JT.

PLoS One. 2018 Jan 18;13(1):e0190416. doi: 10.1371/journal.pone.0190416. eCollection 2018.

15.

Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.

Rothenberg-Thurley M, Amler S, Goerlich D, Köhnke T, Konstandin NP, Schneider S, Sauerland MC, Herold T, Hubmann M, Ksienzyk B, Zellmeier E, Bohlander SK, Subklewe M, Faldum A, Hiddemann W, Braess J, Spiekermann K, Metzeler KH.

Leukemia. 2017 Dec 18. doi: 10.1038/leu.2017.350. [Epub ahead of print]

PMID:
29249818
16.

A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemia.

Herold T, Jurinovic V, Batcha AMN, Bamopoulos SA, Rothenberg-Thurley M, Ksienzyk B, Hartmann L, Greif PA, Phillippou-Massier J, Krebs S, Blum H, Amler S, Schneider S, Konstandin N, Sauerland MC, Görlich D, Berdel WE, Wörmann BJ, Tischer J, Subklewe M, Bohlander SK, Braess J, Hiddemann W, Metzeler KH, Mansmann U, Spiekermann K.

Haematologica. 2018 Mar;103(3):456-465. doi: 10.3324/haematol.2017.178442. Epub 2017 Dec 14.

17.

Testing a potential alternative to traditional identification procedures: Reaction time-based concealed information test does not work for lineups with cooperative witnesses.

Sauerland M, Wolfs ACF, Crans S, Verschuere B.

Psychol Res. 2019 Sep;83(6):1210-1222. doi: 10.1007/s00426-017-0948-5. Epub 2017 Nov 27.

18.

Computer Mediated Social Comparative Feedback Does Not Affect Metacognitive Regulation of Memory Reports.

Rechdan J, Sauer JD, Hope L, Sauerland M, Ost J, Merckelbach H.

Front Psychol. 2017 Aug 25;8:1433. doi: 10.3389/fpsyg.2017.01433. eCollection 2017.

19.

Therapy of older persons with acute myeloid leukaemia.

Krug U, Gale RP, Berdel WE, Müller-Tidow C, Stelljes M, Metzeler K, Sauerland MC, Hiddemann W, Büchner T.

Leuk Res. 2017 Sep;60:1-10. doi: 10.1016/j.leukres.2017.05.020. Epub 2017 Jun 1. Review.

PMID:
28618329
20.

Masking the Identities of Celebrities and Personally Familiar Individuals: Effects on Visual and Auditory Recognition Performance.

Krix AC, Sauerland M, Schreuder MJ.

Perception. 2017 Oct;46(10):1133-1150. doi: 10.1177/0301006617710621. Epub 2017 May 30.

PMID:
28555531
21.
22.

The Impact of Testing on the Formation of Children's and Adults' False Memories.

Brackmann N, Otgaar H, Sauerland M, Howe ML.

Appl Cogn Psychol. 2016 Sep-Oct;30(5):785-794. Epub 2016 Jul 19.

23.

Stress, stress-induced cortisol responses, and eyewitness identification performance.

Sauerland M, Raymaekers LH, Otgaar H, Memon A, Waltjen TT, Nivo M, Slegers C, Broers NJ, Smeets T.

Behav Sci Law. 2016 Jul;34(4):580-94. doi: 10.1002/bsl.2249. Epub 2016 Jul 15.

24.

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, Görlich D, Schneider S, Konstandin NP, Dufour A, Bräundl K, Ksienzyk B, Zellmeier E, Hartmann L, Greif PA, Fiegl M, Subklewe M, Bohlander SK, Krug U, Faldum A, Berdel WE, Wörmann B, Büchner T, Hiddemann W, Braess J, Spiekermann K; AMLCG Study Group.

Blood. 2016 Aug 4;128(5):686-98. doi: 10.1182/blood-2016-01-693879. Epub 2016 Jun 10.

25.

ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation.

Hartmann L, Dutta S, Opatz S, Vosberg S, Reiter K, Leubolt G, Metzeler KH, Herold T, Bamopoulos SA, Bräundl K, Zellmeier E, Ksienzyk B, Konstandin NP, Schneider S, Hopfner KP, Graf A, Krebs S, Blum H, Middeke JM, Stölzel F, Thiede C, Wolf S, Bohlander SK, Preiss C, Chen-Wichmann L, Wichmann C, Sauerland MC, Büchner T, Berdel WE, Wörmann BJ, Braess J, Hiddemann W, Spiekermann K, Greif PA.

Nat Commun. 2016 Jun 2;7:11733. doi: 10.1038/ncomms11733.

26.

Multiplex PCR assay underreports true bloodstream infections with coagulase-negative staphylococci in hematological patients with febrile neutropenia.

Reers Y, Idelevich EA, Pätkau H, Sauerland MC, Tafelski S, Nachtigall I, Berdel WE, Peters G, Silling G, Becker K; Molecular Diagnostics of Sepsis Study Group.

Diagn Microbiol Infect Dis. 2016 Aug;85(4):413-5. doi: 10.1016/j.diagmicrobio.2016.04.024. Epub 2016 May 5.

PMID:
27220608
27.

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia.

Büchner T, Krug UO, Peter Gale R, Heinecke A, Sauerland MC, Haferlach C, Schnittger S, Haferlach T, Müller-Tidow C, Stelljes M, Mesters RM, Serve HL, Braess J, Spiekermann K, Staib P, Grüneisen A, Reichle A, Balleisen L, Eimermacher H, Giagounidis A, Rasche H, Lengfelder E, Görlich D, Faldum A, Köpcke W, Hehlmann R, Wörmann BJ, Berdel WE, Hiddemann W.

Leukemia. 2016 Aug;30(8):1781-4. doi: 10.1038/leu.2016.54. Epub 2016 Mar 11. No abstract available.

PMID:
26965440
28.

Increasing intensity of therapies assigned at diagnosis does not improve survival of adults with acute myeloid leukemia.

Krug U, Berdel WE, Gale RP, Haferlach C, Schnittger S, Müller-Tidow C, Braess J, Spiekermann K, Staib P, Beelen D, Serve H, Schliemann C, Stelljes M, Balleisen L, Maschmeyer G, Grüneisen A, Eimermacher H, Giagounidis A, Rasche H, Hehlmann R, Lengfelder E, Thiel E, Reichle A, Aul C, Ludwig WD, Kern W, Haferlach T, Köpcke W, Görlich D, Sauerland MC, Heinecke A, Wörmann BJ, Hiddemann W, Büchner T.

Leukemia. 2016 Jun;30(6):1230-6. doi: 10.1038/leu.2016.25. Epub 2016 Feb 9.

PMID:
26859081
29.

These two are different. Yes, they're the same: Choice blindness for facial identity.

Sauerland M, Sagana A, Siegmann K, Heiligers D, Merckelbach H, Jenkins R.

Conscious Cogn. 2016 Feb;40:93-104. doi: 10.1016/j.concog.2016.01.003. Epub 2016 Jan 12.

PMID:
26774209
30.

A 4-gene expression score associated with high levels of Wilms Tumor-1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia.

Niavarani A, Herold T, Reyal Y, Sauerland MC, Buchner T, Hiddemann W, Bohlander SK, Valk PJ, Bonnet D.

Br J Haematol. 2016 Feb;172(3):401-11. doi: 10.1111/bjh.13836. Epub 2015 Nov 24.

31.

When Children are the Least Vulnerable to False Memories: A True Report or a Case of Autosuggestion?

Brackmann N, Otgaar H, Sauerland M, Jelicic M.

J Forensic Sci. 2016 Jan;61 Suppl 1:S271-5. doi: 10.1111/1556-4029.12926. Epub 2015 Aug 7.

PMID:
26249311
32.

Factors influencing life satisfaction in acute myeloid leukemia survivors following allogeneic stem cell transplantation: a cross-sectional study.

Amler S, Sauerland MC, Deiters C, Büchner T, Schumacher A.

Health Qual Life Outcomes. 2015 Feb 27;13:28. doi: 10.1186/s12955-015-0222-8.

33.

Consistency across repeated eyewitness interviews: contrasting police detectives' beliefs with actual eyewitness performance.

Krix AC, Sauerland M, Lorei C, Rispens I.

PLoS One. 2015 Feb 19;10(2):e0118641. doi: 10.1371/journal.pone.0118641. eCollection 2015.

34.

Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.

Lengfelder E, Lo-Coco F, Ades L, Montesinos P, Grimwade D, Kishore B, Ramadan SM, Pagoni M, Breccia M, Huerta AJ, Nloga AM, González-Sanmiguel JD, Schmidt A, Lambert JF, Lehmann S, Di Bona E, Cassinat B, Hofmann WK, Görlich D, Sauerland MC, Fenaux P, Sanz M; European LeukemiaNet.

Leukemia. 2015 May;29(5):1084-91. doi: 10.1038/leu.2015.12. Epub 2015 Jan 28.

PMID:
25627637
35.

Impact of multiplex PCR on antimicrobial treatment in febrile neutropenia: a randomized controlled study.

Idelevich EA, Silling G, Niederbracht Y, Penner H, Sauerland MC, Tafelski S, Nachtigall I, Berdel WE, Peters G, Becker K; Molecular Diagnostics of Sepsis Study Group.

Med Microbiol Immunol. 2015 Oct;204(5):585-92. doi: 10.1007/s00430-014-0385-7. Epub 2015 Jan 9.

PMID:
25573349
36.

Long-term follow-up of cytogenetically normal CEBPA-mutated AML.

Pastore F, Kling D, Hoster E, Dufour A, Konstandin NP, Schneider S, Sauerland MC, Berdel WE, Buechner T, Woermann B, Braess J, Hiddemann W, Spiekermann K.

J Hematol Oncol. 2014 Sep 10;7:55. doi: 10.1186/s13045-014-0055-7.

37.

Isolated trisomy 13 defines a homogeneous AML subgroup with high frequency of mutations in spliceosome genes and poor prognosis.

Herold T, Metzeler KH, Vosberg S, Hartmann L, Röllig C, Stölzel F, Schneider S, Hubmann M, Zellmeier E, Ksienzyk B, Jurinovic V, Pasalic Z, Kakadia PM, Dufour A, Graf A, Krebs S, Blum H, Sauerland MC, Büchner T, Berdel WE, Woermann BJ, Bornhäuser M, Ehninger G, Mansmann U, Hiddemann W, Bohlander SK, Spiekermann K, Greif PA.

Blood. 2014 Aug 21;124(8):1304-11. doi: 10.1182/blood-2013-12-540716. Epub 2014 Jun 12.

38.

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.

Köhnke T, Sauter D, Ringel K, Hoster E, Laubender RP, Hubmann M, Bohlander SK, Kakadia PM, Schneider S, Dufour A, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Braess J, Hiddemann W, Spiekermann K, Subklewe M.

Leukemia. 2015 Feb;29(2):377-86. doi: 10.1038/leu.2014.186. Epub 2014 Jun 10.

PMID:
24912430
39.

Memory impairment is not sufficient for choice blindness to occur.

Sagana A, Sauerland M, Merckelbach H.

Front Psychol. 2014 May 20;5:449. doi: 10.3389/fpsyg.2014.00449. eCollection 2014.

40.

Self-relevance does not moderate choice blindness in adolescents and children.

Sauerland M, Sagana A, Otgaar H, Broers NJ.

PLoS One. 2014 Jun 2;9(6):e98563. doi: 10.1371/journal.pone.0098563. eCollection 2014.

41.

Molecular response assessment by quantitative real-time polymerase chain reaction after induction therapy in NPM1-mutated patients identifies those at high risk of relapse.

Hubmann M, Köhnke T, Hoster E, Schneider S, Dufour A, Zellmeier E, Fiegl M, Braess J, Bohlander SK, Subklewe M, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Hiddemann W, Spiekermann K.

Haematologica. 2014 Aug;99(8):1317-25. doi: 10.3324/haematol.2014.104133. Epub 2014 May 9.

42.

Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.

Pastore F, Dufour A, Benthaus T, Metzeler KH, Maharry KS, Schneider S, Ksienzyk B, Mellert G, Zellmeier E, Kakadia PM, Unterhalt M, Feuring-Buske M, Buske C, Braess J, Sauerland MC, Heinecke A, Krug U, Berdel WE, Buechner T, Woermann B, Hiddemann W, Bohlander SK, Marcucci G, Spiekermann K, Bloomfield CD, Hoster E.

J Clin Oncol. 2014 May 20;32(15):1586-94. doi: 10.1200/JCO.2013.52.3480. Epub 2014 Apr 7.

43.

Super-leadership and work enjoyment: direct and moderated influences.

Müller GF, Georgianna S, Schermelleh-Engel K, Roth AC, Schreiber WA, Sauerland M, Muessigmann MJ, Jilg F.

Psychol Rep. 2013 Dec;113(3):804-21.

PMID:
24693813
44.

Speaking is silver, writing is golden? The role of cognitive and social factors in written versus spoken witness accounts.

Sauerland M, Krix AC, van Kan N, Glunz S, Sak A.

Mem Cognit. 2014 Aug;42(6):978-92. doi: 10.3758/s13421-014-0401-6.

PMID:
24604628
45.

Allogeneic transplantation versus chemotherapy as postremission therapy for acute myeloid leukemia: a prospective matched pairs analysis.

Stelljes M, Krug U, Beelen DW, Braess J, Sauerland MC, Heinecke A, Ligges S, Sauer T, Tschanter P, Thoennissen GB, Berning B, Kolb HJ, Reichle A, Holler E, Schwerdtfeger R, Arnold R, Scheid C, Müller-Tidow C, Woermann BJ, Hiddemann W, Berdel WE, Büchner T.

J Clin Oncol. 2014 Feb 1;32(4):288-96. doi: 10.1200/JCO.2013.50.5768. Epub 2013 Dec 23.

PMID:
24366930
46.

Novel shifts in memory research and their impact on the legal process: introduction to the special issue on memory formation and suggestibility in the legal process.

Otgaar H, Sauerland M, Petrila JP.

Behav Sci Law. 2013 Sep-Oct;31(5):531-40. doi: 10.1002/bsl.2095. Epub 2013 Sep 30.

PMID:
24108575
47.

Witnesses' blindness for their own facial recognition decisions: a field study.

Sagana A, Sauerland M, Merckelbach H.

Behav Sci Law. 2013 Sep-Oct;31(5):624-36. doi: 10.1002/bsl.2082. Epub 2013 Sep 9.

PMID:
24019073
48.

Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial.

Serve H, Krug U, Wagner R, Sauerland MC, Heinecke A, Brunnberg U, Schaich M, Ottmann O, Duyster J, Wandt H, Fischer T, Giagounidis A, Neubauer A, Reichle A, Aulitzky W, Noppeney R, Blau I, Kunzmann V, Stuhlmann R, Krämer A, Kreuzer KA, Brandts C, Steffen B, Thiede C, Müller-Tidow C, Ehninger G, Berdel WE.

J Clin Oncol. 2013 Sep 1;31(25):3110-8. doi: 10.1200/JCO.2012.46.4990. Epub 2013 Jul 29.

PMID:
23897964
49.

Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia.

Opatz S, Polzer H, Herold T, Konstandin NP, Ksienzyk B, Zellmeier E, Vosberg S, Graf A, Krebs S, Blum H, Hopfner KP, Kakadia PM, Schneider S, Dufour A, Braess J, Sauerland MC, Berdel WE, Büchner T, Woermann BJ, Hiddemann W, Spiekermann K, Bohlander SK, Greif PA.

Blood. 2013 Sep 5;122(10):1761-9. doi: 10.1182/blood-2013-01-476473. Epub 2013 Jul 22.

50.

Developmental trends in different types of spontaneous false memories: implications for the legal field.

Otgaar H, Howe ML, Peters M, Sauerland M, Raymaekers L.

Behav Sci Law. 2013 Sep-Oct;31(5):666-82. doi: 10.1002/bsl.2076. Epub 2013 Jul 9.

PMID:
23839901

Supplemental Content

Loading ...
Support Center